🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

659 results for “MS” Clear

  1. Spikevax 50 micrograms dispersion for injection in pre-filled syringe COVID-19 mRNA Vaccine

    Moderna Biotech Spain

    SARS-CoV-2 infection

    approved small molecule active

    1 trial

  2. Sulfato de Magnesio Altan 150 mg/ml solución inyectable y para perfusión EFG, LIDOCAINE HYDROCHLORIDE, Dexdor 100 micrograms/ml concentrate for solution for infusion, KETOLAR 50 mg/ml solución inyectable.

    The George Institute

    Obesity

    approved small molecule active

    1 trial

  3. Tamsulosin Oral Capsule

    The First People's Hospital of Lianyungang

    Ischaemic Heart Disease (IHD)

    approved small molecule completed

    1 trial

  4. Temozolomide

    Monte Rosa Therapeutics

    Brain Neoplasms, Malignant, Primary

    approved small molecule completed

    1 trial

  5. Terrosa 20 micrograms/80 microliters solution for injection in pre-filled pen, Acido Alendronico Aurobindo 70 mg compresse

    Gedeon Richter Australia Pty Ltd

    Prevention of new morphometric vertebral fractures and/or worsening of previous vertebral fractures.

    approved small molecule active

    1 trial

  6. The placebo MDI is formulated as a suspension of spray-dried porous particles (consisting of 1,2-distearoyl-sn-glycero-3-phosphocholine [DSPC] and calcium chloride) in a hydrofluoroalkane propellant (HFA-134a). The placebo MDI uses the same excipients as active product but with absence of the active pharmaceutical ingredient (API)., Trixeo Aerosphere 5 micrograms/7.2 micrograms/160 micrograms pressurised inhalation, suspension

    AstraZeneca AB

    Chronic Obstructive Pulmonary Disease

    approved small molecule active

    1 trial

  7. Vemurafenib

    Hoffmann-La Roche

    Neoplasms

    approved small molecule completed

    1 trial

  8. a control group

    The First People's Hospital of Lianyungang

    Disorder of Stomach Function and Feeding Problems in Newborn

    approved small molecule completed

    1 trial

  9. doxazosin plus tolterodine SR

    Samsung Bioepis NL B.V.

    Overactive Bladder

    approved small molecule completed

    1 trial

  10. fluocinolone acetonide 190 micrograms

    ANI PHARMACEUTICALS INC

    Non-infectious Uveitis Affecting the Posterior Segment of the Eye

    approved small molecule active

    1 trial

  11. mesenchymal stromal cells

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    MSC

    approved mab active

    1 trial

  12. temsirolimus

    Pfizer

    Non-Hodgkin's Lymphoma

    approved small molecule completed

    1 trial

  13. 20 grams protein

    United Therapeutics Europe Ltd

    Muscle Disuse

    other active

    1 trial

  14. 68Ga-Her2-affibody

    The First People's Hospital of Lianyungang

    Neoplasms

    small molecule active

    1 trial

  15. Docetaxel

    The First People's Hospital of Lianyungang

    Esophageal Neoplasms

    small molecule active

    1 trial

  16. FGFR Inhibitor, IDH1 Inhibitor, HER2 Inhibitor, PARP Inhibitor, BRAF Inhibitor, MEK Inhibitor, ICIs, EGFR-TKIs, NTRK-TKI, and et. al.

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Biliary Tract Neoplasms

    small molecule active

    1 trial

  17. Follitropin Beta;MSD

    Reproductive & Genetic Hospital of CITIC-Xiangya

    Infertility

    small molecule completed

    1 trial

  18. HFMS, MRC, ACTIVLIM, PedsQl-4.0

    United Therapeutics Europe Ltd

    Flaccid Hemiplegia

    other active

    1 trial

  19. Hydrochloride anlotinib

    Zhongnan Hospital

    Uterine Cervical Neoplasms

    small molecule active

    1 trial

  20. IORT

    The First People's Hospital of Lianyungang

    Laryngeal Neoplasms

    other active

    1 trial

  21. Lidocaine IV

    Samsung Bioepis NL B.V.

    Colorectal Cancer

    small molecule completed

    1 trial

  22. PIMS screening

    The First People's Hospital of Lianyungang

    PGT-A

    gene therapy active

    1 trial

  23. POHIM-RT

    Samsung Bioepis NL B.V.

    Cervix Cancer

    other active

    1 trial

  24. Partially Hydrolyzed Whey Protein Formula

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Mild Allergic Symptoms in Infants

    other active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources